Skip to main content

What do you think of our new website?

We’ve made some improvements to its design, information, and performance. Please tell us if we can do anything better. Give feedback

Ministry of Health
  1. Home
  2. Managing expenses
  3. Schemes and subsidies
  4. List of subsidised drugs

List of subsidised drugs

MOH provides drug subsidies at public hospitals, specialist outpatient clinics, and polyclinics. This ensures patients can access effective medications for common medical conditions in Singapore.

Last updated 21 November 2024

List of Drugs* (as of 1 November 2024)

*The drug availability at each healthcare institution varies, depending on the clinical conditions commonly managed by the institution and the drugs usually prescribed by the doctors.

Search the list

Active Ingredient(s)

Dosage Form

Strength(s)

Subsidy Class

Clinical Indication (where applicable)

Abacavir & Lamivudine

Tablet

Abacavir 600 mg + Lamivudine 300 mg

SDL


Abacavir, Dolutegravir & Lamivudine

Tablet

Abacavir 600 mg + Dolutegravir 50 mg + Lamivudine 300 mg

SDL


Abemaciclib

Tablet

50 mg, 100 mg, 150 mg

MAF

1) Abemaciclib in combination with an aromatase inhibitor as initial endocrine-based therapy for HR positive, HER2 negative, advanced or metastatic breast cancer. Pre/perimenopausal women treated with this combination could also receive a luteinizing hormone-releasing hormone agonist according to local clinical practice.

2) Abemaciclib in combination with fulvestrant for treating HR positive, HER2 negative, advanced or metastatic breast cancer in patients who have received prior endocrine therapy. Pre/perimenopausal women treated with this combination could also receive a luteinizing hormone-releasing hormone agonist according to local clinical practice.

3) Abemaciclib in combination with endocrine therapy for adjuvant treatment of patients with HR positive, HER2 negative, node-positive early breast cancer at high risk of recurrence. Maxiumum treatment duration: 2 years.

Abiraterone Acetate

Tablet

250 mg

SDL


Abrocitinib

Tablet

50 mg, 100 mg, 200 mg

MAF

Additional clinical criteria applies

Treatment of moderate to severe atopic dermatitis (AD)

Absolute Alcohol

Injection

1

SDL


Acalabrutinib

Capsule

100 mg

MAF

1) Monotherapy for previously untreated chronic lymphocytic leukaemia (CLL) or small lymphocytic lymphoma (SLL) in patients who are unsuitable for fludarabine-based therapy

2) Monotherapy for chronic lymphocytic leukaemia (CLL) or small lymphocytic lymphoma (SLL) in patients who have received at least one prior therapy

3) Treatment of patients with mantle cell lymphoma (MCL) who have received at least one prior therapy

Acalabrutinib

Tablet

100 mg

MAF

1) Monotherapy for previously untreated chronic lymphocytic leukaemia (CLL) or small lymphocytic lymphoma (SLL) in patients who are unsuitable for fludarabine-based therapy

2) Monotherapy for chronic lymphocytic leukaemia (CLL) or small lymphocytic lymphoma (SLL) in patients who have received at least one prior therapy

3) Treatment of patients with mantle cell lymphoma (MCL) who have received at least one prior therapy

Acetazolamide

Tablet

250 mg

SDL


Acetic acid

Ear drops

2%, 3%, 4%, 5%

SDL